BioLineRx (Nasdaq: BLRX) reported the establishment of a Scientific Advisory Board (SAB) to provide insight and guidance on the Company’s ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE